BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26723758)

  • 1. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
    Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
    Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
    Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning for Outcomes (P
    Lebetkin E; Gao X; Taylor D; Maldonado LY; Saad A; Steiner MJ; Dorflinger LJ; Nanda K; Mastro TD
    Glob Health Sci Pract; 2019 Jun; 7(2):317-328. PubMed ID: 31189699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
    Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
    Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
    Kleinschmidt I; Rees H; Delany S; Smith D; Dinat N; Nkala B; McIntyre JA
    Contraception; 2007 Jun; 75(6):461-7. PubMed ID: 17519153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-Evaluating the Possible Increased Risk of HIV Acquisition With Progestin-Only Injectables Versus Maternal Mortality and Life Expectancy in Africa: A Decision Analysis.
    Rodriguez MI; Gaffield ME; Han L; Caughey AB
    Glob Health Sci Pract; 2017 Dec; 5(4):581-591. PubMed ID: 29284696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.
    Heffron R; Donnell D; Rees H; Celum C; Mugo N; Were E; de Bruyn G; Nakku-Joloba E; Ngure K; Kiarie J; Coombs RW; Baeten JM;
    Lancet Infect Dis; 2012 Jan; 12(1):19-26. PubMed ID: 21975269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa.
    Moodley J; Naidoo S; Wand H; Ramjee G;
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):5-11. PubMed ID: 26259895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
    Crook AM; Ford D; Gafos M; Hayes R; Kamali A; Kapiga S; Nunn A; Chisembele M; Ramjee G; Rees H; McCormack S
    Hum Reprod; 2014 Aug; 29(8):1810-7. PubMed ID: 24838704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
    AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response.
    Nene Z; Hofmeyr GJ; Patel M; Panday M; Rees H; Makua M; Pillay Y
    S Afr Med J; 2018 Jul; 108(8):629-631. PubMed ID: 30182875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.
    Wall KM; Kilembe W; Vwalika B; Htee Khu N; Brill I; Chomba E; Johnson BA; Haddad L; Tichacek A; Allen S
    Contraception; 2015 Jun; 91(6):480-7. PubMed ID: 25708502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa.
    McCoy SI; Zheng W; Montgomery ET; Blanchard K; van der Straten A; de Bruyn G; Padian NS
    AIDS; 2013 Mar; 27(6):1001-1009. PubMed ID: 23698064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
    Buckner LR; Drobnis EZ; Augustine MS; Rogers LK; Akers J; Mott PD; Hope TJ; Quayle AJ; Schust DJ
    PLoS One; 2019; 14(5):e0214152. PubMed ID: 31095572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda.
    Kiddugavu M; Makumbi F; Wawer MJ; Serwadda D; Sewankambo NK; Wabwire-Mangen F; Lutalo T; Meehan M; Xianbin ; Gray RH;
    AIDS; 2003 Jan; 17(2):233-40. PubMed ID: 12545084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
    Hapgood JP; Kaushic C; Hel Z
    Endocr Rev; 2018 Feb; 39(1):36-78. PubMed ID: 29309550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.